Delayed emesis: moderately emetogenic chemotherapy

被引：0
|
作者：
Fausto Roila
David Warr
Rebecca A. Clark-Snow
Maurizio Tonato
Richard J. Gralla
Lawrence H. Einhorn
Jorn Herrstedt
机构：
[1] Policlinico Hospital,Medical Oncology Division
[2] Princess Margaret Hospital,Department of Medical Oncology and Hematology
[3] University of Kansas Cancer Center,Medical Oncology Division
[4] Policlinico Hospital,Department of Oncology
[5] New York Lung Cancer Alliance,undefined
[6] Walther Cancer Institute,undefined
[7] Copenhagen University Hospital Herlev,undefined
来源：
Supportive Care in Cancer | 2005年 / 13卷
关键词：
Delayed emesis; Moderately emetogenic chemotherapy; Dexamethasone; 5-HT; antagonist;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Data on the incidence and efficacy of antiemetic prophylaxis against delayed emesis induced by moderately emetogenic chemotherapy are scanty. An overview of the literature has been done that showed the efficacy of dexamethasone in two of three randomized trials. Its optimal dose and duration of administration has not been defined. Only one of four randomized studies showed a statistically significant efficacy of 5-HT3 antagonists. Finally, only weak evidence has been published on the efficacy of dopamine receptor antagonists.
引用
收藏
页码：104 / 108
页数：4
相关论文
共 50 条
  • [1] Delayed emesis: moderately emetogenic chemotherapy
    Roila, F
    Warr, D
    Clark-Snow, RA
    Tonato, M
    Gralla, RJ
    Einhorn, LH
    Herrstedt, J
    [J]. SUPPORTIVE CARE IN CANCER, 2005, 13 (02) : 104 - 108
  • [2] Acute emesis: moderately emetogenic chemotherapy
    Jørn Herrstedt
    Bernardo Rapoport
    David Warr
    Fausto Roila
    Emilio Bria
    Cynthia Rittenberg
    Paul J. Hesketh
    [J]. Supportive Care in Cancer, 2011, 19 : 15 - 23
  • [3] Acute emesis: moderately emetogenic chemotherapy
    Herrstedt, J
    Koeller, JM
    Roila, F
    Hesketh, PJ
    Warr, D
    Rittenberg, C
    Dicato, M
    [J]. SUPPORTIVE CARE IN CANCER, 2005, 13 (02) : 97 - 103
  • [4] Acute emesis: moderately emetogenic chemotherapy
    Jørn Herrstedt
    Jim M. Koeller
    Fausto Roila
    Paul J. Hesketh
    David Warr
    Cynthia Rittenberg
    Mario Dicato
    [J]. Supportive Care in Cancer, 2005, 13 : 97 - 103
  • [5] Acute emesis: moderately emetogenic chemotherapy
    Herrstedt, Jorn
    Rapoport, Bernardo
    Warr, David
    Roila, Fausto
    Bria, Emilio
    Rittenberg, Cynthia
    Hesketh, Paul J.
    [J]. SUPPORTIVE CARE IN CANCER, 2011, 19 : S15 - S23
  • [6] Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only)
    Fausto Roila
    David Warr
    Matti Aapro
    Rebecca A. Clark-Snow
    Larry Einhorn
    Richard J. Gralla
    Jorn Herrstedt
    Mitsue Saito
    Maurizio Tonato
    [J]. Supportive Care in Cancer, 2011, 19 : 57 - 62
  • [7] Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only)
    Roila, Fausto
    Warr, David
    Aapro, Matti
    Clark-Snow, Rebecca A.
    Einhorn, Larry
    Gralla, Richard J.
    Herrstedt, Jorn
    Saito, Mitsue
    Tonato, Maurizio
    [J]. SUPPORTIVE CARE IN CANCER, 2011, 19 : S57 - S62
  • [8] Role of maintenance oral dexamethasone in prophylaxis of delayed emesis caused by moderately emetogenic chemotherapy
    Koo, WH
    Ang, PT
    [J]. ANNALS OF ONCOLOGY, 1996, 7 (01) : 71 - 74
  • [9] Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy
    Vardy, J.
    Chiew, K.
    Galica, J.
    Pond, G.
    Tannock, I.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 366 - 366
  • [10] Delayed emesis induced by moderately emetogenic chemotherapy: Do we need to treat all patients?
    Ballatori, E
    Roila, F
    DeAngelis, V
    Riva, E
    Barbieri, P
    DelFavero, A
    Basurto, C
    Ciccarese, G
    Palladino, MA
    Mosconi, AM
    Anastasi, P
    Picciafuoco, M
    Campora, E
    Chiara, S
    Cognetti, F
    Ferraresi, V
    Fabi, A
    Tonachella, R
    Cirulli, S
    Sabbatini, R
    Federico, M
    Trassoldati, A
    Silingardi, V
    Donati, D
    Maestri, A
    Malacarne, P
    Ricci, S
    Antonuzzo, A
    Allegrini, G
    Conte, PF
    Salvati, F
    Nunziati, F
    Antilli, A
    Catalano, G
    Cascinu, S
    DiCostanzo, F
    Tagliaventi, M
    Zaniboni, A
    Meriggi, F
    Cortesi, E
    Ramponi, S
    Locatelli, MC
    Santoro, A
    Zucchinelli, P
    Mantellini, E
    Ferretti, G
    Boni, C
    Moretti, G
    Scagliotti, G
    Daniele, O
    [J]. ANNALS OF ONCOLOGY, 1997, 8 (06) : 561 - 567
12345